Clincosm LogoSign in Get a demo

hematologic neoplasms

Showing 1 - 25 of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Jun 5, 2023

Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +3 more
  • RD13-02 cell infusion
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Jun 8, 2023

Prospective Validation of the OHI Index

Recruiting
  • HLH
  • +4 more
    • Kfar Saba, Israel
    • +1 more
    May 21, 2023

    Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

    Not yet recruiting
    • Hematologic Malignancy
    • +2 more
    • Flow Cytometry
    • Nanjing, Jiangsu, China
    • +2 more
    Apr 17, 2023

    Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 6, 2023

    Hematologic Tumors Trial in France (Allogeneic (Allo) hematopoietic stem cell transplantation)

    Completed
    • Hematologic Neoplasms
    • Allogeneic (Allo) hematopoietic stem cell transplantation
    • Amiens, France
    • +13 more
    Jan 27, 2023

    Tissue Specimens From Solid Tumors or Blood Disorders and Their

    Recruiting
    • Neoplasms
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

      Not yet recruiting
      • Hematologic Neoplasms
      • +5 more
      • umbilical cord derived mesenchymal stem cells
      • Wuhan, Hubei, China
      • +2 more
      Jan 3, 2023

      Hematologic Tumors Trial in Canada (Tranexamic Acid)

      Recruiting
      • Hematologic Neoplasms
      • Tranexamic Acid
      • Calgary, Alberta, Canada
      • +10 more
      Dec 12, 2022

      Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

      Recruiting
      • Neoplasms
      • +2 more
      • La Jolla, California
      • +15 more
      Dec 7, 2022

      Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

      Suspended
      • Hematologic Neoplasms
      • donor lymphocyte infusion
      • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Nov 30, 2022

      Hematologic Tumors Trial in Nanjing (virtual reality device)

      Recruiting
      • Hematologic Neoplasms
      • virtual reality device
      • Nanjing, Jiangsu, China
        the First Affiliated Hospital of Nanjing Medical University
      Oct 28, 2022

      Hypoxic Red Blood Cells for Burns and Hematological Malignancies

      Recruiting
      • Hematologic Neoplasms
      • Burns
      • Hypoxic Red Blood Cells
      • Bergen, Norway
        Haukeland University Hospital
      Sep 19, 2022

      Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

      Recruiting
      • Leukemia
      • +19 more
      • CYNK-001
      • Denver, Colorado
      • +9 more
      Sep 9, 2022

      Hematologic Tumors, Solid Tumor Trial in Madison (PMMTB (Precision Medicine Molecular Tumor Board))

      Recruiting
      • Hematologic Neoplasms
      • Solid Neoplasm
      • PMMTB (Precision Medicine Molecular Tumor Board)
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Jul 7, 2022

      Hematologic Tumors, Hemorrhage, Hematopoietic Stem Cell Transplantation Trial in Australia, United Kingdom (Tranexamic acid

      Completed
      • Hematologic Neoplasms
      • +2 more
      • Tranexamic acid (TXA).
      • Placebo
      • Adelaide, Australia
      • +27 more
      Jun 20, 2022

      Febrile Neutropenia, Solid Tumor, Hematologic Tumors Trial in Clamart, Le Kremlin-Bicêtre (NEUTROSIS)

      Completed
      • Febrile Neutropenia
      • +2 more
      • NEUTROSIS
      • Clamart, France
      • +2 more
      May 2, 2022

      Cognitive Impairment, Hematologic Tumors, Hematopoietic Cell Transplant Trial in Birmingham (Lumosity, Lumosity (waitlist

      Recruiting
      • Cognitive Impairment
      • +2 more
      • Lumosity
      • Lumosity (waitlist control)
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Apr 25, 2022

      What Matters Most to Patients: Establishing Validity

      Recruiting
      • Hematologic Neoplasms
      • Assessment Surveys
      • Qualitative Interviews
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center
      Apr 11, 2022

      GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)

      Recruiting
      • GVHD
      • Hematologic Neoplasms
      • La Jolla, California
        UC San Diego Moores Cancer Center
      Mar 21, 2022

      Cancer of Unknown Origin, Cancer Refractory, Cancer of Stomach Trial in Austria (Genomic testing)

      Recruiting
      • Cancer of Unknown Origin
      • +14 more
      • Genomic testing
      • Feldkirch, Austria
      • +10 more
      Feb 18, 2022

      Genomic Sequencing to Find Potential Targets for Personalized

      Completed
      • Hematologic Neoplasms
        • Aurora, Colorado
          University of Colorado Cancer Center
        Feb 8, 2022

        COVID-19 After Autologous Hematopoietic Stem Cell

        Completed
        • Covid19
        • +4 more
        • Autologous stem cell transplantation
        • Uppsala, Sweden
          Uppsala Universitet
        Feb 7, 2022

        Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals

        Recruiting
        • Hematologic Neoplasms
        • COVID-19 Vaccines
        • S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests
        • +2 more
        • Vilnius, Lithuania
          Vilnius University Hospital Santaros Klinikos
        Dec 27, 2021